FDA budget supplemental for AIDS and orphan drugs
Executive Summary
Supplemental appropriation of $12 mil. for FDA, includes $1.5 mil. for expanded work with AIDS and $500,000 for development of orphan drugs and devices. Also $5.9 mil. of the new funds will go towards pay raises given government workers earlier in the year and $4.1 mil. for agency contributions to the new Federal Employees Retirement System. The new funding for FDA is part of a $9 bil. additional appropriation for federal agencies for the current fiscal year signed by President Reagan on July 11. The extra funding gives FDA an operating budget of $450 mil. for FY 87.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.